Core Insights - The defense and aerospace industry is experiencing sustained high demand, particularly in the two aircraft sectors and commercial aerospace, which are seen as new growth drivers [2][5][13] - The report highlights the increasing frequency of commercial space launches, with companies like SpaceX targeting a valuation of $1.5 trillion as they prepare for an IPO [5][14] - Investment opportunities are identified in various sectors, including domestic demand and overseas expansion, AI-driven upgrades in military technology, and the potential for new materials and technologies in aviation and space [5][15] Industry Overview - The report notes that the demand for high-end aviation equipment is expected to continue, with significant opportunities for domestic engine replacements in the civil aviation market [23] - The commercial aerospace sector is seeing a notable increase in aircraft deliveries, with a reported 44% year-on-year growth in the delivery of wide-body aircraft as of October 2025 [5][13] - The report emphasizes the importance of strategic partnerships, such as the long-term supply agreement between Yingliu Aviation and Ansaldo Energia, which marks a shift towards large-scale collaboration [5][13] Company Analysis - Companies like AVIC Shenyang Aircraft Corporation and AVIC Xi'an Aircraft Industry Group are highlighted for their potential to benefit from increased domestic and international demand [15][29] - The report discusses the strong growth prospects for companies involved in AI-driven military upgrades, recommending a focus on firms like Ruichuang Micro-Nano and AVIC Optoelectronics [15][18] - The financial outlook for key companies is optimistic, with projected earnings growth and favorable valuation metrics, such as a dynamic PE ratio of approximately 40X for Ruichuang Micro-Nano [18][19] Market Performance - The report indicates that the China Securities Military Industry Index has shown a weekly increase of 2.53%, with a year-to-date increase of 27.99% as of the report date [36] - The military sector has outperformed major indices, indicating strong investor interest and confidence in the defense and aerospace markets [36] Investment Recommendations - The report suggests focusing on companies that are well-positioned to capitalize on the expanding domestic and international markets, particularly those involved in military and aerospace technology [15][23] - Specific companies recommended for investment include AVIC Shenyang, AVIC Xi'an, and Ruichuang Micro-Nano, among others, due to their strategic positioning and growth potential [15][18][29]

Re-listing - Enjie Co., Ltd. plans to acquire 100% of Zhongke Hualian, a high-tech enterprise specializing in the research and development of wet lithium-ion battery separator production equipment and other polymer material production equipment, leading to the resumption of its stock trading [1] - Guoao Technology's actual controller has changed to Xu Yinghui, resulting in the resumption of its stock trading [2] Capital Increase and Mergers - Tiens Wind Power plans to raise 1.95 billion yuan for the expansion of the Changfeng New Energy Equipment Manufacturing Base and other related projects [3] - Rese Intelligent plans to raise no more than 1.144 billion yuan for the development and industrialization of core components for intelligent equipment motion control and other projects [4] - Tiankang Biological intends to acquire 51% of Xinjiang Qiangdu Animal Husbandry Technology Co., Ltd. for 1.275 billion yuan in cash [5] Share Transfer and Buyback - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan to reduce the company's registered capital [6] - Xice Testing's controlling shareholder Li Zexin intends to transfer 4.22 million shares at a price of 48.59 yuan per share, accounting for 5% [7] - Jintian Titanium Industry is inquiring about a share transfer price of 15.39 yuan per share for a total of 22.6625 million shares [8] External Investment and Daily Operations - Saiyi Information received approval for a major national science and technology project related to intelligent manufacturing systems and robotics [9] - Jiuan Medical's U.S. subsidiary received pre-market notification from the FDA for a home test kit for multiple viruses [10] - Jiazhe New Energy plans to invest in two wind power projects with a total installed capacity of 450 MW and an investment of approximately 2.366 billion yuan [11] - Junshi Biosciences received FDA approval for clinical trials of JS212 for the treatment of advanced malignant solid tumors [12] - Longsheng Technology plans to invest 350 million yuan in an innovative center for embodied intelligent robots [13] - Watson Bio's subsidiary received approval for clinical trials of a freeze-dried shingles virus mRNA vaccine [14] - Greeenmei plans to acquire 16.38% of Henan Circular Technology Industry Group for 400 million yuan [15] - Heng Rui Medicine's HRS9531 injection clinical trial has been approved, with no similar drugs approved globally for the MASH indication [16] - Guodian Power plans to invest 7.218 billion yuan in the expansion of the Guoneng Jianbi Phase 8 project [17] - Guorui Technology's subsidiary won a bid for the "GXLF Project Pump Source" project with a bid of 76 million yuan [18] - Xin Fengming plans to invest 280 million USD in a 360,000-ton functional fiber project in Egypt [19] - Chip Origin terminated the acquisition of 97% of Chip Lai Zhirong [20] - Moore Thread plans to use 7.5 billion yuan of idle raised funds for cash management [21]

行业研究 证 券 研 究 报 告 华创交运|低空经济周报（第 59 期） 多地政府十五五规划建议写入"低空经济" 邮箱：wuyifan@hcyjs.com 执业编号：S0360516090002 证券分析师：梁婉怡 邮箱：liangwanyi@hcyjs.com 执业编号：S0360523080001 证券分析师：吴晨玥 交通运输 2025 年 12 月 14 日 邮箱：wuchenyue@hcyjs.com 执业编号：S0360523070001 推荐（维持） 证券分析师：霍鹏浩 邮箱：huopenghao@hcyjs.com 执业编号：S0360524030001 华创证券研究所 证券分析师：吴一凡 证券分析师：李清影 邮箱：liqingying@hcyjs.com 执业编号：S0360525080004 联系人：刘邢雨 邮箱：liuxingyu@hcyjs.com 行业基本数据 | | | 占比% | | --- | --- | --- | | 股票家数(只) | 121 | 0.02 | | 总市值(亿元) | 33,163.64 | 2.78 | | 流通市值(亿元) | 28,692.20 | 2 ...

关于子公司项目预中标的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 近期，国睿科技股份有限公司接到子公司芜湖国睿兆伏电子有限公司（简称国睿兆伏）通知，国睿兆伏 投标的"GXLF项目片放泵浦源"项目发布了评标结果，国睿兆伏为该项目的中标候选人，该结果在中国 工程物理研究院招投标信息网（ztbxx.caep.ac.cn）上进行了公示，公示期为2025年12月8日至2025年12 月12日。 本次项目招标人为中国工程物理研究院激光聚变研究中心，项目内容为根据片放泵浦源功能及技术指标 要求完成相应的工程设计、加工制造、安装集成与调试、验收交付等工作。国睿兆伏对该项目的投标报 价为人民币76,000,000.00元（柒仟陆佰万元整）。 证券代码：600562 证券简称：国睿科技 公告编号：2025-034 国睿科技股份有限公司 国睿兆伏后续将在收到中标通知书后，履行合同签订等程序，敬请投资者注意投资风险。 特此公告。 国睿科技股份有限公司董事会 2025年12月13日 ...

Mergers and Acquisitions - Moore Threads plans to use no more than 7.5 billion yuan of idle raised funds for cash management [3] - Tian康 Bio intends to acquire 51% equity of Qiangdu Livestock for 1.275 billion yuan [3] - Greenmeadow plans to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [3] - Chongqing Water intends to acquire a sewage treatment project for 382 million yuan [3] - Enjie shares plans to acquire 100% equity of Zhongke Hualian, with stock resuming trading [3] - Rongbai Technology plans to acquire part of the equity of Guizhou Xinren and increase capital to achieve control [3] - Jiahuan Energy plans to merge with its wholly-owned subsidiary Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd. [3] Financing Activities - Guangzhou Development received a registration notice for 8 billion yuan medium-term notes and 6 billion yuan short-term financing bonds [3] - Poly Development plans to issue convertible bonds to raise no more than 5 billion yuan [3] - Liaoning Chengda's 3 billion yuan medium-term notes have been approved for registration [3] - Tianyu Bio's application for issuing A-shares to specific targets in 2025 has been accepted by the Shanghai Stock Exchange [3] - Tonglian Precision's application for issuing convertible bonds to unspecified targets has been approved by the Shanghai Stock Exchange [3] Shareholding Changes - Xice Testing's actual controller plans to transfer 5% of the company's shares through an agreement [3] - China High-Tech's control is set to change, with stock suspension starting December 15 [3] Buybacks and Shareholding Adjustments - Oppein Home's actual controller and concerted actors plan to increase their holdings of company shares by 50 million to 100 million yuan [3] - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan [3] - Xilong Science's private equity intends to reduce its holdings by no more than 1% of the company's shares [3] - Jincheng shares' actual controller and concerted actors plan to reduce their holdings by no more than 0.97% [3] Operational Data - China Merchants Port reported a container throughput of 17.248 million TEUs in November, a year-on-year increase of 6.4% [4] Major Investments - New Fengming plans to invest 280 million USD in a 360,000 tons/year functional fiber project in Egypt [5] - Tian Shun Wind Power plans to raise no more than 1.95 billion yuan for the expansion of the Changfeng New Energy Equipment Manufacturing Base [5] - Lei Sai Intelligent plans to raise no more than 1.144 billion yuan for core components of intelligent equipment motion control [5] - Hainan Development's subsidiary plans to invest 215 million yuan in the second phase of the Zhuhai production base [5]

Group 1 - Moer Thread plans to use up to 7.5 billion yuan of idle raised funds for cash management, with a usage period of 12 months [1] - O-film plans to purchase 8.46% equity of its subsidiary Anhui Che Lian for a total of 3.64 billion yuan, increasing its ownership from 78.54% to 87% [2] - ST Lian Shi applies to revoke the delisting risk warning as its restructuring plan has been completed [3] Group 2 - Weirli signs a strategic cooperation framework agreement with Primech Holdings to build an industrial robot cooperation platform [4] - Race Intelligent plans to raise no more than 1.144 billion yuan through a private placement for core components of intelligent equipment [5] - Renfu Pharmaceutical's stock will be subject to other risk warnings and will be suspended for one day starting December 15 [6] Group 3 - Yongding Co. clarifies that its subsidiary Dongbu Superconductor does not directly manufacture controllable nuclear fusion devices [7] - Rongbai Technology plans to acquire part of Guizhou Xinren's equity and increase its capital to achieve control [9] - ST Hu Ke is under investigation by the Securities Regulatory Commission for suspected information disclosure violations [10] Group 4 - Yunnan Ge Industry plans to establish a subsidiary focused on organic germanium-related products [11] - Greenme intends to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [12] - Jiangzhong Pharmaceutical plans to change its name to China Resources Jiangzhong Pharmaceutical [13] Group 5 - Jiangsu Guoxin's subsidiary Ma Zhou Power has completed the trial operation of a 1,000 MW coal-fired power generation unit [16] - Longsheng Technology plans to invest in a center for embodied intelligent robots [18] - Guangzhou Development has received approval for the registration of 8 billion yuan medium-term notes and 6 billion yuan short-term financing notes [19] Group 6 - China Merchants Port reported a container throughput of 17.248 million TEUs in November, a year-on-year increase of 6.4% [20] - Tianma Technology reported a total eel output of approximately 11,415.87 tons from January to November [21] Group 7 - Xilong Science plans to reduce its stake by up to 1% [22] - Xicet Testing's actual controller plans to transfer 5% of the company's shares [23] - Oppein Home's actual controller plans to increase its stake by 50 million to 100 million yuan [24] Group 8 - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan [25] - Baicheng Pharmaceutical's major shareholder increased its stake by 0.85% [26] - Mengbaihe's major shareholder plans to reduce its stake by up to 1% [27] Group 9 - Xian Dao Ji Dian's shareholder has reduced its stake by 1.70% [28] - Yaxiang Integration's shareholder reduced its stake by 41,400 shares [29] - Zhiwei Intelligent's actual controller has reduced its stake, bringing the total holding to 69% [30] Group 10 - Jincheng Co.'s actual controller plans to reduce its stake by up to 0.97% [31] - Jianghua Micro's chairman has reduced his stake by 1.09% [32] - COSCO Shipping Energy signed a shipbuilding contract worth 7.882 billion yuan [33] Group 11 - Dayu Water Saving's subsidiary is expected to win two high-standard farmland construction projects [34] - Guorui Technology's subsidiary is a candidate for the GXLF project [36] - ST Zhisheng has won a smart city governance project worth 104 million yuan [37]

Monetary Policy - As of the end of November, the broad money supply (M2) in China reached 336.99 trillion yuan, reflecting a year-on-year growth of 8% [1] - The narrow money supply (M1) stood at 112.89 trillion yuan, with a year-on-year increase of 4.9% [1] - The currency in circulation (M0) amounted to 13.74 trillion yuan, showing a year-on-year growth of 10.6% [1] - A net cash injection of 917.5 billion yuan occurred in the first eleven months of the year [1] Banking and Financial Services - The total scale of bank wealth management products has reached a historic high of approximately 33.8 trillion yuan, nearing 34 trillion yuan [2] - In the first eleven months, 14 wealth management companies collectively grew by about 3.43 trillion yuan, with "fixed income plus" products contributing an additional 1.32 trillion yuan [2] - The market saw a significant increase of 1.67 trillion yuan in the fourth quarter alone, accounting for nearly half of the annual growth [2] Regulatory Developments - The China Securities Investment Fund Industry Association has drafted a consultation document to standardize fund sales behavior, aiming to prevent misleading practices and protect investor rights [2] - The document outlines clear requirements for fund promotion, sales information disclosure, and performance assessment [2] Corporate Actions - Taihao Technology plans to use 13.67 billion yuan from its capital reserves to cover significant losses, a move that reflects a broader trend among A-share companies to address accumulated losses amid new regulatory changes [4] - Over 30 listed companies have announced similar plans to utilize capital reserves to offset losses, with total amounts exceeding 30 billion yuan [4] Market Trends - The top ten wafer foundries reported a quarter-on-quarter revenue increase of 8.1% in Q3 2025, driven by demand for AI and consumer electronics [4] - The global wafer foundry industry is expected to face challenges in 2026 due to international market conditions and conservative demand forecasts [4] Industry Developments - A new company, Beijing Guanghe Qiancheng Technology, has been established by leading silicon material firms, marking a significant step towards reducing overcapacity in the photovoltaic industry [5] - Future silicon material production capacity is planned to be capped at 1.5 million tons [5] Legal and Compliance Issues - The China Securities Regulatory Commission has penalized three individuals for manipulating the stock of Shandong Jincheng Pharmaceutical Group, resulting in fines and market bans [3] - Huayi Brothers' founder has received a consumption restriction order due to an advertising contract dispute, with the company facing a financial penalty of over 11.4 million yuan [8] IPO and Market Activity - Youyan Composite Materials has received approval for its IPO on the Sci-Tech Innovation Board [9] - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange [10] Corporate Changes - The chairman of Jinling Hotel has resigned due to work changes, leaving the company without any executive positions held by him [11] - *ST Chang Pharmaceutical's subsidiary has recently ceased operations due to financial difficulties and competitive pressures in the photovoltaic sector [12] Project Announcements - Jiangsu Guoxin's subsidiary has successfully completed the trial operation of a new 1000MW coal-fired power generation unit [13] - *ST Zhisheng has won a 1.04 billion yuan contract for a smart city governance project, significantly impacting its projected annual revenue [17]

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]

近期，国睿科技股份有限公司接到子公司芜湖国睿兆伏电子有限公司（简称 国睿兆伏）通知，国睿兆伏投标的"GXLF 项目片放泵浦源"项目发布了评标结 果，国睿兆伏为该项目的中标候选人，该结果在中国工程物理研究院招投标信息 网（ztbxx.caep.ac.cn）上进行了公示，公示期为 2025 年 12 月 8 日至 2025 年 12 月 12 日。 本次项目招标人为中国工程物理研究院激光聚变研究中心，项目内容为根据 片放泵浦源功能及技术指标要求完成相应的工程设计、加工制造、安装集成与调 试、验收交付等工作。国睿兆伏对该项目的投标报价为人民币 76,000,000.00 元（柒仟陆佰万元整）。 证券代码：600562 证券简称：国睿科技 公告编号：2025-034 国睿科技股份有限公司 关于子公司项目预中标的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 国睿兆伏后续将在收到中标通知书后，履行合同签订等程序，敬请投资者注 意投资风险。 特此公告。 国睿科技股份有限公司董事会 2025 年 12 月 13 日 ...

本次项目招标人为中国工程物理研究院激光聚变研究中心，项目内容为根据片放泵浦源功能及技术指标 要求完成相应的工程设计、加工制造、安装集成与调试、验收交付等工作。国睿兆伏对该项目的投标报 价为人民币7600万元（柒仟陆佰万元整）。 格隆汇12月12日丨国睿科技(600562.SH)公布，近期，国睿科技股份有限公司接到子公司芜湖国睿兆伏 电子有限公司通知，国睿兆伏投标的"GXLF 项目片放泵浦源"项目发布了评标结果，国睿兆伏为该项目 的中标候选人，该结果在中国工程物理研究院招投标信息网上进行了公示，公示期为2025年12月8日至 2025年12月12日。 ...